Back to Journals » Therapeutics and Clinical Risk Management » Biologic Treatment for Allergic Disease

Therapeutics and Clinical Risk Management

COPE logo
ISSN: 1178-203X

Journal Articles:

Biologic Treatment for Allergic Disease

Since their clinical introduction, biologic treatments, particularly monoclonal antibodies, have transformed patient care, offering targeted therapies and improved outcomes for conditions including allergic asthma, allergic rhinitis, atopic dermatitis and urticaria. Given the importance of biologics in managing allergic disease, we here collect original research articles, reviews, and perspectives exploring the mechanisms of action, clinical efficacy, safety, and real-world application of these therapies.